RHY.AX stock analysis: 476% potential upside targets major biotech breakout — buy or sell

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_video&utm_medium=explainer_video&utm_campaign=freja_and_friends

In this deep dive, we break down Rhythm Biosciences Limited (RHY.AX) and its transition from a pre-revenue R&D entity into a commercial diagnostic enterprise via its breakthrough ColoSTAT bowel cancer blood test and geneType platform. With its revolutionary ColoSTAT test delivering a validated 90.3% sensitivity and the company securing a $5.5 million AUD capital infusion to scale operations, the key question for investors is whether this ASX healthcare micro-cap can successfully achieve self-sustaining cash flow. Here’s everything you need to know before making a decision on RHY.AX.

🎯 SECTIONS:
- Rhythm Biosciences and the Future of Non-Invasive Cancer Diagnostics
- ColoSTAT Blood Test: 90.3% Sensitivity and Competitive Moat
- The geneType Acquisition: Multiplying the Genomic Market Opportunity
- Revenue Model and Commercial Pathology Partnerships
- Financial Runway Analysis: Option Underwriting and Cash Burn Rate
- Capital Restructuring: The 100-to-1 Share Consolidation Explained
- Five-Year Valuation Scenarios: High, Base, and Low Cases
- Key Operational Risks, Competitor Dynamics, and Regulatory Barriers
- Qualitative Analysis: Management Alignment and Balance Sheet Strength
- The Investment Thesis: Commercial Scaling vs. Execution Risk

All of the institutional-grade research behind this video was generated using Flash by StockSentinel.ai. Flash empowers retail investors with professional-quality tools, offering FREE access to detailed investment research reports on any public company in the world.

Your FREE Flash account includes:
✅ Explainer Videos
✅ Audio Podcasts
✅ Detailed Reports
✅ Investor Presentations with full qualitative and quantitative analysis

For investors looking for an extra edge, premium subscribers also unlock:
✅ Best Ideas Now (6 highest-conviction picks delivered every Saturday)
✅ Portfolio Watch
✅ Insider IQ (real-time alerts on significant global insider buying activity)
✅ Flash Community

Subscribe + 🔔 to never miss a stock report

DISCLAIMER: This content is for informational and educational purposes only and is not investment advice. Opinions are personal and may change. Do your own research or consult a licensed professional. StockSentinel.ai is under no obligation to update this information.

#StockAnalysis #StockMarket #Investing #Stocks #ValueInvesting #StockResearch #InvestmentAnalysis #FinancialAnalysis #RHY #RhythmBiosciences #RHYStock #RHYAnalysis #HealthcareStocks #BiotechStocks #DeepDive #FundamentalAnalysis #ValuationAnalysis #WallStreet #Finance #WealthBuilding

Indra IDR.MC stock analysis: €20.3B backlog signals massive defense rerating - buy or sell

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_video&utm_medium=explainer_video&utm_campaign=freja_and_friends

In this deep dive, we break down Indra Sistemas, S.A. (IDR.MC) and its rapid transition from a low-margin IT consulting firm into a high-moat European aerospace and defense champion. With an order backlog surging 154% to €20.33 billion and first-quarter EBITDA margins expanding to 14.5%, the key question for investors is whether this sovereign tech leader is a buy or sell at current valuations. Here’s everything you need to know before making a decision on IDR.MC.

🎯 SECTIONS:
- The €20.3B Defense and Aerospace Transformation
- Unlocking Shareholder Value: The Minsait IT Divestment Strategy
- Financial Performance: PEM Prepayments and Cash Flow Distortions
- Global Peer Comparison: Indra vs. Thales, Leonardo and Hensoldt
- Risk Assessment: Supply Chain Bottlenecks and Scaling Challenges
- 5-Year Scenarios: Bull, Base, and Bear Case Fair Value Estimates

All the research behind this video was created using Flash by StockSentinel.ai. Flash gives viewers FREE access to investment research reports on any public company.

The FREE features include:
✅ Explainer Videos
✅ Audio Podcasts
✅ Detailed Reports
✅ Investor Presentations with full qualitative and quantitative analysis

Subscribers also unlock:
✅ Best Ideas Now (6 highest-conviction picks every Saturday)
✅ Portfolio Watch
✅ Insider IQ (alerts on significant global insider buying activity)
✅ Flash Community

Subscribe + 🔔 to never miss a stock report

DISCLAIMER: This content is for informational and educational purposes only and is not investment advice. Opinions are personal and may change. Do your own research or consult a licensed professional. StockSentinel.ai is under no obligation to update this information.

#StockAnalysis #StockMarket #Investing #Stocks #ValueInvesting #StockResearch #InvestmentAnalysis #FinancialAnalysis #IDR #IndraSistemas #IDRStock #IDRAnalysis #DefenseStocks #TechStocks #DeepDive #FundamentalAnalysis #ValuationAnalysis #WallStreet #Finance #WealthBuilding

Fluidra FDR.VI locks in 70% recurring revenue — buy or sell stock analysis & valuation

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_video&utm_medium=explainer_video&utm_campaign=freja_and_friends

In this deep dive, we break down Fluidra, S.A. (FDR.VI) and its dominant position as a global leader in pool and wellness equipment, supported by a highly resilient 70% recurring aftermarket revenue loop and a new €120 million Efficiency Plan. With the stock trading at €20.18 and gross margins holding robust at 57.1%, the key question for investors is whether near-term U.S. channel destocking and a slow housing market will derail Fluidra's long-term compounding potential. Here’s everything you need to know before making a decision on FDR.VI.

🎯 SECTIONS:
- Executive Summary & Global Leader Overview
- Vertically Integrated Pool & Wellness Business Model
- The Power of the 70% Non-Discretionary Aftermarket Loop
- Analyzing Fluidra's Core Product Architecture & Technology Moat
- Global Economic Moat & Total Addressable Market (TAM) Analysis
- Competitive Landscape: Hayward, Pentair, and North American Market Share
- Q1 2026 Financial Analysis & Reaffirmed Guidance
- Analyst Sentiment, Price Targets, and Market Reaction
- 5-Year Financial Scenario Analysis (Base, High, and Low Cases)
- Strategic Execution & Macroeconomic Risks to Watch
- Blended Qualitative Scorecard Analysis
- Conclusion & Long-Term Investment Thesis

All the research behind this video was created using Flash by StockSentinel.ai, the premier platform giving viewers FREE access to institutional-grade investment research reports on any public company in the world.

Our FREE features include:
✅ Explainer Videos
✅ Audio Podcasts
✅ Detailed Reports
✅ Investor Presentations with full qualitative and quantitative analysis

To take your investing to the next level, our premium subscribers also unlock:
✅ Best Ideas Now (6 highest-conviction picks every Saturday)
✅ Portfolio Watch
✅ Insider IQ (alerts on significant global insider buying activity)
✅ Flash Community

Subscribe + 🔔 to never miss a stock report

DISCLAIMER: This content is for informational and educational purposes only and is not investment advice. Opinions are personal and may change. Do your own research or consult a licensed professional. StockSentinel.ai is under no obligation to update this information.

#StockAnalysis #StockMarket #Investing #Stocks #ValueInvesting #StockResearch #InvestmentAnalysis #FinancialAnalysis #FDR #Fluidra #FDRStock #FDRAnalysis #IndustrialStocks #ConsumerStocks #DeepDive #FundamentalAnalysis #ValuationAnalysis #WallStreet #Finance #WealthBuilding

Tyler Technologies TYL holds 98% client retention — buy or sell stock analysis & valuation

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_video&utm_medium=explainer_video&utm_campaign=freja_and_friends

In this deep dive, we break down Tyler Technologies Inc (TYL) and its cloud-native transformation that is poised to drive massive recurring revenue growth. With SaaS revenue growing 23.5% YoY in Q1 2026 and operating margins projected to expand over 30%, the key question for investors is whether this defensive GovTech champion is a buy or sell at its current valuation. Here’s everything you need to know before making a decision on TYL.

🎯 SECTIONS:
- Tyler Technologies business model and municipal ERP software dominance
- The SaaS migration engine: cloud conversions and ARR expansion
- Legal-tech M&A and South Carolina's agentic AI assistant rollout
- GovTech competitive moat: high switching costs and public sector RFPs
- Q1 2026 financial analysis: earnings beat, recurring revenue, and cash flow
- Strategic execution risks: contract delays, litigation, and cybersecurity
- 5-Year financial scenario modeling (Bear, Base, and High Cases)
- Valuation multiples, analyst price targets, and long-term stock outlook

All the comprehensive institutional-grade research behind this video was created using Flash by StockSentinel.ai, a powerful platform designed to give viewers FREE access to investment research reports on any public company in the world. As a free member, you immediately gain access to high-value investment tools:
✅ Explainer Videos
✅ Audio Podcasts
✅ Detailed Reports
✅ Investor Presentations with full qualitative and quantitative analysis

Ready to take your investing further? Our premium subscribers also unlock exclusive features to maximize their edge, including:
✅ Best Ideas Now (6 highest-conviction picks every Saturday)
✅ Portfolio Watch
✅ Insider IQ (alerts on significant global insider buying activity)
✅ Flash Community

Subscribe + 🔔 to never miss a stock report

DISCLAIMER: This content is for informational and educational purposes only and is not investment advice. Opinions are personal and may change. Do your own research or consult a licensed professional. StockSentinel.ai is under no obligation to update this information.

#StockAnalysis #StockMarket #Investing #Stocks #ValueInvesting #StockResearch #InvestmentAnalysis #FinancialAnalysis #TYL #TylerTechnologies #TYLStock #TYLAnalysis #TechStocks #SoftwareStocks #DeepDive #FundamentalAnalysis #ValuationAnalysis #WallStreet #NYSE #NASDAQ

CanAsia CEC trades at 94% valuation discount — ultimate asymmetric stock analysis

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_video&utm_medium=explainer_video&utm_campaign=freja_and_friends

In this deep dive, we break down CanAsia Energy Corp. (CEC.V) and the game-changing CAD 26 million non-dilutive partnership with KIGAM that fully funds their Sawn Lake heavy oil restart. With their underlying Sawn Lake asset carrying a risked after-tax NPV10 of CAD 570 million while trading at a massive 94.4% discount to its market capitalization, the key question for investors is whether their patented Produced Water Boiler can successfully validate this technology at commercial scale. Here’s everything you need to know before making a decision on CEC.V.

🎯 SECTIONS:
- Executive Summary & Sawn Lake Bitumen Assets
- The KIGAM CRDA Agreement & CAD 26M Funding Breakthrough
- Solving SAGD Water Costs with Patented Produced Water Boiler Tech
- Sawn Lake Resource Potential & CAD 570M NPV10 Valuation
- Q1 2026 Financial Results & Going Concern Mitigation
- Key Catalyst Timeline: Regulatory Approvals & Thailand Oil Bid
- Operational Execution Risks & 5-Year Scenario Analysis

All the research behind this video was created using Flash by StockSentinel.ai. Flash gives viewers FREE access to investment research reports on any public company.

The FREE features include:
✅ Explainer Videos
✅ Audio Podcasts
✅ Detailed Reports
✅ Investor Presentations with full qualitative and quantitative analysis

Subscribers also unlock:
✅ Best Ideas Now (6 highest-conviction picks every Saturday)
✅ Portfolio Watch
✅ Insider IQ (alerts on significant global insider buying activity)
✅ Flash Community

Subscribe + 🔔 to never miss a stock report

DISCLAIMER: This content is for informational and educational purposes only and is not investment advice. Opinions are personal and may change. Do your own research or consult a licensed professional. StockSentinel.ai is under no obligation to update this information.

#StockAnalysis #StockMarket #Investing #Stocks #ValueInvesting #StockResearch #InvestmentAnalysis #FinancialAnalysis #CEC #CanAsiaEnergyCorp #CECStock #CECAnalysis #EnergyStocks #OilAndGas #EnergyInvesting #DeepDive #FundamentalAnalysis #ValuationAnalysis #StockPicks #InvestingIdeas #StockDD #DueDiligence #WallStreet #NYSE #NASDAQ #Finance #WealthBuilding #PassiveIncome #FinancialFreedom

CEPU stock analysis reveals 6.4x forward P/E — utility valuation breakdown

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_video&utm_medium=explainer_video&utm_campaign=freja_and_friends

In this deep dive, we break down Central Puerto SA (CEPU) and its strategic transition into a diversified energy platform fueled by structural electricity market deregulation. With shares trading at a projected forward valuation of only 6.46x P/E and net leverage comfortable at 1.06x EBITDA, the key question for investors is whether this Argentine utility play represents an asymmetrical buy or a risky value trap. Here’s everything you need to know before making a decision on CEPU.

🎯 SECTIONS:
• Executive Summary and Argentine Grid Overview
• Core Power Generation Assets & Piedra del Aguila Concession
• Diversification Pipeline: Forestry Estates and Vaca Muerta Shale
• Competitive Moat: Off-take PPAs and Fuel Sourcing Advantages
• Q1 2026 Earnings & USD Accounting Integration
• Risk Framework: Sovereign Risk, Debt, and Hydrological Volatility
• 5-Year Scenario Modeling and Probability-Weighted Target Price
• Qualitative Scorecard & Investment Thesis

All the premium research behind this video was created using Flash by StockSentinel.ai. Flash gives viewers FREE access to investment research reports on any public company in the world.

Our FREE features include:
✅ Explainer Videos
✅ Audio Podcasts
✅ Detailed Reports
✅ Investor Presentations with full qualitative and quantitative analysis

Subscribers also unlock:
✅ Best Ideas Now (6 highest-conviction picks every Saturday)
✅ Portfolio Watch
✅ Insider IQ (alerts on significant global insider buying activity)
✅ Flash Community

Subscribe + 🔔 to never miss a stock report

DISCLAIMER: This content is for informational and educational purposes only and is not investment advice. Opinions are personal and may change. Do your own research or consult a licensed professional. StockSentinel.ai is under no obligation to update this information.

#StockAnalysis #StockMarket #Investing #Stocks #ValueInvesting #StockResearch #InvestmentAnalysis #FinancialAnalysis #CEPU #CentralPuerto #CEPUStock #CEPUAnalysis #EnergyStocks #UtilityStocks #DeepDive #FundamentalAnalysis #ValuationAnalysis #WallStreet #NYSE #Finance

Takeda stock analysis: TAK trades at 9.8x Core EPS — buy or sell this deep-value pharma play?

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_video&utm_medium=explainer_video&utm_campaign=freja_and_friends

In this deep dive, we break down Takeda Pharmaceutical Co Ltd (TAK) and its massive pipeline pivot designed to offset the generic erosion of ADHD blockbuster Vyvanse. With shares trading at just 9.8 times trailing core earnings despite several highly competitive Phase 3 pipeline launches on the horizon, the key question for investors is whether this represents a high-yield buy or sell opportunity. Here’s everything you need to know before making a decision on TAK.

🎯 SECTIONS:
- Takeda Pharmaceutical Investment Thesis Summary
- Analyzing the Vyvanse Patent Cliff and Generic Headwinds
- Advanced Psoriasis Trials: Zasocitinib (TAK-279) Clinical Efficacy Comparison
- Late-Stage Blockbuster Catalysts: Oveporexton (TAK-861) and Rusfertide
- High Switching Costs and Economic Moat of Plasma-Derived Immunology
- Deciphering the JPY 402.5 Billion Amitiza Litigation Provision
- Valuation Deep Dive: Trailing vs Forward Core EPS Multiples
- 5-Year Scenarios: Base Case, Bull Case, and Bear Case Projections
- The Ultimate Decision: Is TAK Stock a Buy or Sell?

All the research behind this video was created using Flash by StockSentinel.ai, which gives viewers FREE access to professional-grade investment research reports on any public company in the world. As a free user, you unlock:
✅ Explainer Videos
✅ Audio Podcasts
✅ Detailed Reports
✅ Investor Presentations with full qualitative and quantitative analysis

For investors looking for an extra edge, premium subscribers also unlock:
✅ Best Ideas Now (6 highest-conviction picks every Saturday)
✅ Portfolio Watch
✅ Insider IQ (alerts on significant global insider buying activity)
✅ Flash Community

Subscribe + 🔔 to never miss a stock report

DISCLAIMER: This content is for informational and educational purposes only and is not investment advice. Opinions are personal and may change. Do your own research or consult a licensed professional. StockSentinel.ai is under no obligation to update this information.

#StockAnalysis #StockMarket #Investing #Stocks #ValueInvesting #StockResearch #InvestmentAnalysis #FinancialAnalysis #TAK #TakedaPharmaceutical #TAKStock #TAKAnalysis #HealthcareStocks #PharmaStocks #DeepDive #FundamentalAnalysis #ValuationAnalysis #StockPicks #NYSE #Finance

GRVY holds 88% cash-backed valuation — stock analysis buy or sell deep dive

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_video&utm_medium=explainer_video&utm_campaign=freja_and_friends

In this deep dive, we break down Gravity Co Ltd (GRVY) and the massive potential valuation re-rating triggered by its upcoming game launches and a major shift in capital allocation. With cash reserves backing nearly 88% of its market capitalization and the stock trading at just 1.1x EV/EBITDA, the key question for investors is whether its new interim dividend will finally unlock this massive cash pile. Here’s everything you need to know before making a decision on GRVY.

🎯 SECTIONS:
- Executive Summary & Company Overview
- The Power & Durability of the Ragnarok IP
- Analyzing the Core Mobile & PC Game Segments
- The Massive Balance Sheet & Cash Coffer
- Deep Discount Valuation & EV/EBITDA Breakdown
- Corporate Governance & the PFIC Tax Restraints
- Upcoming Catalysts: Ragnarok Online 3 in China
- Strategic Shift: Dividend Announcement Analysis
- 5-Year Scenario Modeling & Probability-Weighted Targets

All the research behind this video was created using Flash by StockSentinel.ai, which gives viewers FREE access to professional investment research reports on any public company.

Free features on Flash include:
✅ Explainer Videos
✅ Audio Podcasts
✅ Detailed Reports
✅ Investor Presentations with full qualitative and quantitative analysis

Looking for an edge? Premium subscribers also unlock:
✅ Best Ideas Now (6 highest-conviction picks every Saturday)
✅ Portfolio Watch
✅ Insider IQ (alerts on significant global insider buying activity)
✅ Flash Community

Subscribe + 🔔 to never miss a stock report

DISCLAIMER: This content is for informational and educational purposes only and is not investment advice. Opinions are personal and may change. Do your own research or consult a licensed professional. StockSentinel.ai is under no obligation to update this information.

#StockAnalysis #StockMarket #Investing #Stocks #ValueInvesting #StockResearch #InvestmentAnalysis #FinancialAnalysis #GRVY #GravityCoLtd #GRVYStock #GRVYAnalysis #GamingStocks #TechStocks #DeepDive #FundamentalAnalysis #ValuationAnalysis #WallStreet #NASDAQ #Finance

TPG0 stock analysis hits a crazy 0.47x P/E despite 51% growth — buy or sell deep dive

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_video&utm_medium=explainer_video&utm_campaign=freja_and_friends

In this deep dive, we break down The Platform Group AG (TPG0.DE) and the dramatic divergence between its stellar operating results and its distressed market valuation. With net revenue surging 51.2% year-over-year in Q1 2026 but shares trading at an unprecedented 0.47x trailing P/E ratio, the key question for investors is whether this is an extraordinary buying opportunity or an asymmetric risk. Here’s everything you need to know before making a decision on TPG0.DE.

🎯 SECTIONS:
- The Platform Group E-Commerce Enablement Model
- Inside TPG ONE: Software & Scalable Middleware
- High Switching Costs & Indirect Network Effects
- Q1 2026 Earnings Review & Operating Momentum
- The Pending €1B AEP Pharma Acquisition Catalyst
- Financial Health, Debt Structure, & Nordic Bond Refinancing
- Corporate Governance & Media Controversy Breakdown
- The Stark 0.47x P/E Valuation Disconnect Analyzed
- 5-Year Return Scenario Analysis (High, Base, & Low Cases)
- Blended Qualitative Scorecard & Final Stock Analysis

All the research behind this stock analysis was created using Flash by StockSentinel.ai. Flash gives you completely FREE access to institutional-grade investment research reports on any public company in the world.

Your free access includes:
✅ Explainer Videos
✅ Audio Podcasts
✅ Detailed Reports
✅ Investor Presentations with full qualitative and quantitative analysis

Want to take your investing to the next level? Subscribers also unlock:
✅ Best Ideas Now (6 highest-conviction picks every Saturday)
✅ Portfolio Watch
✅ Insider IQ (alerts on significant global insider buying activity)
✅ Flash Community

Subscribe + 🔔 to never miss a stock report

DISCLAIMER: This content is for informational and educational purposes only and is not investment advice. Opinions are personal and may change. Do your own research or consult a licensed professional. StockSentinel.ai is under no obligation to update this information.

#StockAnalysis #StockMarket #Investing #Stocks #ValueInvesting #StockResearch #InvestmentAnalysis #FinancialAnalysis #TPG0 #ThePlatformGroup #TPG0Stock #TPG0Analysis #TechStocks #ConsumerStocks #DeepDive #FundamentalAnalysis #ValuationAnalysis #WallStreet #Finance #WealthBuilding

ZTO Express reveals 67% undervaluation — ultimate buy or sell stock analysis & valuation

👉 Want this level of research on ANY COMPANY IN THE WORLD... for FREE? Check us out at: https://flash.stocksentinel.ai/?utm_source=rss_video&utm_medium=explainer_video&utm_campaign=freja_and_friends

In this deep dive, we break down ZTO Express (Cayman) Inc (ZTO) and its undisputed 20.3% market share dominance in China's express delivery industry. With shares trading at a highly discounted trailing P/E of 13.65x while expanding Q1 2026 revenue by 22% YoY, the key question for investors is whether this lowest-cost operator is a definitive buy or if margin pressures pose a structural threat. Here’s everything you need to know before making a decision on ZTO.

🎯 SECTIONS:
- Executive Summary: China's Market Leader by Volume
- Business Drivers: Core Express Delivery & Reverse Logistics
- Moat Analysis: Scale-Driven Unit Cost Reductions
- Chinese Courier Market & Industry Trends
- Competitor Landscape: Tongda Peers vs. Vertical Integration
- Q1 2026 Financial Results & Margin Compression Analysis
- 5-Year Scenario Modeling: Target Price & Upside Analysis
- Core Investment Risks: Platform Integration & Wage Inflation
- Valuation Metrics: Multiples Comparison to Global Peers
- Technical Outlook & Short-Term Share Price Action

All the research behind this video was created using Flash by StockSentinel.ai, giving you institutional-grade equity analysis. Flash gives viewers FREE access to professional investment research reports on any public company in the world.

The FREE features include:
✅ Explainer Videos
✅ Audio Podcasts
✅ Detailed Reports
✅ Investor Presentations with full qualitative and quantitative analysis

Subscribers also unlock premium tools to find the highest-conviction ideas:
✅ Best Ideas Now (6 highest-conviction picks every Saturday)
✅ Portfolio Watch
✅ Insider IQ (alerts on significant global insider buying activity)
✅ Flash Community

Subscribe + 🔔 to never miss a stock report

DISCLAIMER: This content is for informational and educational purposes only and is not investment advice. Opinions are personal and may change. Do your own research or consult a licensed professional. StockSentinel.ai is under no obligation to update this information.

#StockAnalysis #StockMarket #Investing #Stocks #ValueInvesting #StockResearch #InvestmentAnalysis #FinancialAnalysis #ZTO #ZTOExpress #ZTOStock #ZTOAnalysis #ConsumerStocks #DeepDive #FundamentalAnalysis #ValuationAnalysis #WallStreet #NYSE